“GLP-1s mess up or stop your period.”
What the evidence shows
Menstrual disruption is not a listed effect of GLP-1 drugs, and the studied direction is often the opposite. In women with PCOS — where high insulin and excess weight drive irregular or absent periods — meta-analyses of trials report improved menstrual regularity with GLP-1 treatment, largely through weight loss and better insulin sensitivity. So for a common group of users, cycles frequently become more regular, not less.
What we still don’t know
The PCOS menstrual data are low-certainty (short trials, older drugs), and there's little formal study of cycle changes in women without PCOS. Separately, rapid or substantial weight loss by any method can temporarily disturb menstruation, and a missed period is also how pregnancy announces itself — a real possibility given restored fertility on these drugs. These threads haven't been cleanly separated in research, so an individual's cycle change can have several causes.
Why the claim misleads
'Mess up or stop your period' frames a non-established, indirect, and often-favorable effect as a direct drug harm. For many PCOS users the honest story is improved regularity. When a period does go missing, the useful response isn't to blame the drug reflexively — it's to consider weight-loss effects and, importantly, rule out pregnancy, and to raise persistent changes with a clinician rather than a forum.
Graded by The Peptide Era · evidence, not hype